國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Success in the ottom of the pyramid ...

Carlowitz, Philipp von.

Success in the ottom of the pyramid market in Africathe case of multinational pharmaceutical companies /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Success in the ottom of the pyramid market in Africaby Philipp von Carlowitz.
其他題名:	the case of multinational pharmaceutical companies /
作者:	Carlowitz, Philipp von.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	xv, 120 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Pharmaceutical industryAfrica.
電子資源:	https://doi.org/10.1007/978-3-030-59068-0
ISBN:	9783030590680$q(electronic bk.)

Success in the ottom of the pyramid market in Africathe case of multinational pharmaceutical companies /
Carlowitz, Philipp von.

Success in the ottom of the pyramid market in Africathe case of multinational pharmaceutical companies /[electronic resource] :by Philipp von Carlowitz. - Cham :Springer International Publishing :2020. - xv, 120 p. :ill., digital ;24 cm. - SpringerBriefs in business,2191-5482. - SpringerBriefs in business..

This book presents an empirical investigation of the efforts that multinational pharmaceutical companies take in order to find a business model that allows for a profitable access to the Bottom of the Pyramid (BoP) markets. The Bottom of the Pyramid in Africa is frequently mentioned as an attractive market due to its sheer size. Yet most companies struggle to access it because of the low price level, difficult physical market access and challenges when it comes to payment. More specifically, the book investigates the following business model-related questions: Do pharmaceutical companies provide products that meet the needs of the BoP? What characterizes the value generation of the company? What revenue model leads to a profitable business, and what role does a network of partners play in the business model? Findings reveal that there is no 'one-size-fits-all' answer to these questions. Providing continuous availability, affordability at a good quality of goods and services, creating health awareness, as well as localizing business to achieve a level of inclusivenessare essential prerequisites for success. In the last chapter this book provides a business model prototype that accounts for these key success factors for business at the Bottom of the Pyramid and points to further research topics.

ISBN: 9783030590680$q(electronic bk.)

Standard No.: 10.1007/978-3-030-59068-0doiSubjects--Topical Terms:

741040
Pharmaceutical industry
--Africa.

LC Class. No.: HD9673.A2 / C375 2020

Dewey Class. No.: 381.456151096

Success in the ottom of the pyramid market in Africathe case of multinational pharmaceutical companies /
LDR:02396nmm a2200325 a 4500 001 589459
003 DE-He213
005 20210226171959.0
006 m d
007 cr nn 008maaau
008 210601s2020 sz s 0 eng d
020 $a 9783030590680$q(electronic bk.)
020 $a 9783030590673$q(paper)
024 7 $a 10.1007/978-3-030-59068-0 $2 doi
035 $a 978-3-030-59068-0
040 $a GP $c GP
041 0 $a eng
050 4 $a HD9673.A2 $b C375 2020
072 7 $a KC $2 bicssc
072 7 $a BUS069000 $2 bisacsh
072 7 $a KC $2 thema
082 0 4 $a 381.456151096 $2 23
090 $a HD9673.A2 $b C284 2020
100 1 $a Carlowitz, Philipp von. $3 881288
245 1 0 $a Success in the ottom of the pyramid market in Africa $h [electronic resource] : $b the case of multinational pharmaceutical companies / $c by Philipp von Carlowitz.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a xv, 120 p. : $b ill., digital ; $c 24 cm.
490 1 $a SpringerBriefs in business, $x 2191-5482
520 $a This book presents an empirical investigation of the efforts that multinational pharmaceutical companies take in order to find a business model that allows for a profitable access to the Bottom of the Pyramid (BoP) markets. The Bottom of the Pyramid in Africa is frequently mentioned as an attractive market due to its sheer size. Yet most companies struggle to access it because of the low price level, difficult physical market access and challenges when it comes to payment. More specifically, the book investigates the following business model-related questions: Do pharmaceutical companies provide products that meet the needs of the BoP? What characterizes the value generation of the company? What revenue model leads to a profitable business, and what role does a network of partners play in the business model? Findings reveal that there is no 'one-size-fits-all' answer to these questions. Providing continuous availability, affordability at a good quality of goods and services, creating health awareness, as well as localizing business to achieve a level of inclusivenessare essential prerequisites for success. In the last chapter this book provides a business model prototype that accounts for these key success factors for business at the Bottom of the Pyramid and points to further research topics.
650 0 $a Pharmaceutical industry $z Africa. $3 741040
650 0 $a International business enterprises. $3 183603
650 0 $a Economic development $z Africa. $3 475631
650 1 4 $a African Economics. $3 773877
650 2 4 $a African Business. $3 779340
650 2 4 $a Sales/Distribution. $3 737137
650 2 4 $a Pharmacoeconomics and Health Outcomes. $3 696758
650 2 4 $a Emerging Markets/Globalization. $3 557943
650 2 4 $a Health Care Management. $3 674996
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a SpringerBriefs in business. $3 558493
856 4 0 $u https://doi.org/10.1007/978-3-030-59068-0
950 $a Economics and Finance (SpringerNature-41170)